Dasatinib Targets B-Lineage Cells but Does Not Provide an Effective Therapy for Myeloproliferative Disease in c-Cbl RING Finger Mutant Mice
Johanna M. Duyvestyn(University of Western Australia), Wallace Y. Langdon(University of Western Australia)
Cited by 12
Related Papers
Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice
|Experimental Hematology|2014|18
The targeting of human and mouse B lymphocytes by dasatinib
|Experimental Hematology|2015|8